Differential expression of α2-adrenoceptor vs. imidazoline binding sites in postmortem orbitofrontal cortex and amygdala of depressed subjects

Journal of Psychiatric Research

Volumn 37, Issue 5, 2003, Pages 399-409

  Piletz, John E ^a   Ordway, Gregory A ^a   Rajkowska, Grazyna ^a,b   Zhu, He ^a   Klimek, Violeta ^a   Swilley, Sharonda ^a   Duncan, Betty J ^a   May, Warren ^a   Halaris, Angelos E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; CLONIDINE; IMIDAZOLINE; TRITIUM;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BRAIN; CADAVER; CONTROLLED STUDY; DEPRESSION; DRUG BINDING SITE; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIVARIATE ANALYSIS; ORBITAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; STATISTICAL SIGNIFICANCE;

EID: 0038721966     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(03)00046-3     Document Type: Article

References (50)

1. Ahmadi-Abhari S.A., Akhondzadeh S., Assadi S.M., Shabestari O.L., Farzanehgan Z.M., Kamlipour A. Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial. J Clin Pharm Ther. 26:2001;67-71.
2. Andreasen N.C., Endicott J., Spitzer R.L., Winokur G. The family history method using diagnostic criteria. reliability and validity Arch. Gen. Psychiat. 34:1977;1229-1235.
3. 3H]cirazoline as a tool for the characterization of imidazoline sites. Ann N Y Acad Sci. 763:1995;112-124.
4. Arango V., Ernsberger P., Sved P., Mann J.J. Quantitative autoradiography of alpha-1 and alpha-2 adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Research. 630:1993;271-282.
5. Biegon A., Wolff M. Quantitative histochemistry of acetylcholinesterase in rat and human brain postmortem. J Neurosci Methods. 16:1986;39-45.
6. 1-imidazoline and alpha-2 adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. Journal of Pharmacology and Experimental Therapeutics. 273:1995;1162-1171.
7. Callado L.F., Meana J.J., Grijalba B., Pazos A., Sastre M., Garcia-Sevilla J.A. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. Journal of Neurochemistry. 70:1998;1114-1123.
8. Chen M., Zhu H., Piletz J. Molecular interaction between alpha2A adrenergic and imidazoline receptors. Biological Psychiatry. 49:2001;387. 111S.
9. Coull J.T., Nobre A.C., Frith C.D. The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. Cereb Cortex. 11:2001;73-84.
10. Curet O., de Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminal alpha 2-adrenergic autoreceptors. Brain Res. 499:1989;18-26.
11. Davidson R.J. Anxiety and affective style. role of prefrontal cortex and amygdala Biol Psychiatry. 51:2002;68-80.
12. De Paermentier F., Mauger J.M., Lowther S., Crompton M.R., Katona C.L., Horton R.W. Brain alpha-adrenoceptors in depressed suicides. Brain Res. 757:1997;60-68.
13. DeVos H., Bricca G., DeKeyser J., DeBacker J., Bousquet P., Vauquelin G. Imidazoline receptors, non-adrenergic idazoxan binding sites,and alpha-2 adrenoceptors in the human central nervous system. Neuroscience. 59:1994;589-598.
14. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci. 877:1999;614-637.
15. Endicott J., Spitzer R.L. A diagnostic interview. the schedule for affective disorders and schizophrenia Arch Gen Psychiatry. 35:1978;837-844.
16. Ernsberger P., Giuliano R., Willette R.N., Reis D.J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther. 253:1990;408-418.
17. 1-Imidazoline receptors. Definition, characterization, distribution and transmembrane signalling Annals New York Academy of Sciences. 763:1995;22-42.
18. 1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla. American Journal of Physiology. 42:1997;R1572-R1579.
19. 1 imidazoline sites. Annals of New York Academy of Sciences. 763:1995;163-168.
20. Escriba P.V., Ozaita A., Garcia-Sevilla J.A. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods. Annals New York Academy of Sciences. 881:1999;8-25.
21. Fu C.H., Reed L.J., Meyer J.H., Kennedy S., Houle S., Eisfeld B.S., Brown G.M. Noradrenergic dysfunction in the prefrontal cortex in depression. an [15O] H2O PET study of the neuromodulatory effects of clonidine Biol Psychiatry. 49:2001;317-325.
22. Garcia-Sevilla J.A., Escriba P.V., Ozaita A., La Harpe R., Walzer C., Eytan A., Guimon J. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J Neurochem. 72:1999;282-291.
23. Garcia-Sevilla J.A., Escriba P., Sastre M., Walzer C., Busquets X., Jaquet G.et al. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch Gen Psychiatry. 53:1996;803-810.
24. Garcia-Sevilla J.A., Sastre M., Escriba P.V. Age-dependent increases of immunoreactive imidazoline receptors in the human brain; possible association of a 29/30 kDa protein with the I2 imidazoline receptor identified by [3H]idazoxan. Neuroscience Letters. 184:1995;133-136.
25. Giannini A.J., Sullivan B., Sarachene J., Loiselle R.H. Clonidine in the treatment of premenstrual syndrome. a subgroup study J Clin Psychiatry. 49:1988;62-63.
26. Gonzalez A.M., Pascual J., Meana J.J., Barturen F., del Arco C., Pazos A., Garcia-Sevilla J.A. Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J Neurochem. 63:1994;256-265.
27. Gourlay S.G., Stead L.F., Benowitz N.L. Clonidine for smoking cessation. Cochrane Database Syst Rev. 2000;59.
28. Gross-Isseroff R., Weizman A., Fieldust S.J., Israeli M., Biegon A. Unaltered alpha(2)-noradrenergic/imidazoline receptors in suicide victims. a postmortem brain autoradiographic analysis Eur Neuropsychopharmacol. 10:2000;265-271.
29. 1 imidazoline receptors in cardiovascular regulation. the place of rilmenidine Am J Hypertens. 13:2000;89. S-98S.
30. Hunt R.D., Minderaa R.B., Cohen D.J. Clonidine benefits children with attention deficit disorder and hyperactivity. report of a double-blind placebo-crossover therapeutic trial J Am Acad Child Psychiatry. 24:1985;617-629.
31. Jouvent R., Lecrubier Y., Puech A.J., Simon P., Widlocher D. Antimanic effect of clonidine. American Journal of Psychiatry. 137:1980;1275-1276.
32. Klimek V., Rajkowska G., Luker S.N., Dilley G., Meltzer H.Y., Overholser J.C.et al. Brain noradrenergic receptors in major depression and schizophrenia. Neuropsychopharmacology. 21:1999;69-81.
33. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., Ordway G.A. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci. 17:1997;8451-8458.
34. Leckman J.F., Hardin M.T., Riddle M.A., Stevenson J., Ort S.I., Cohen D.J. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry. 48:1991;324-328.
35. Malgady R.G., Rogler L.H., Tryon W.W. Issues of validity in the Diagnostic Interview Schedule. J Psychiatr Res. 26:1992;59-67.
36. Meana J.J., Barturen F., Garcia-Sevilla J.A. Alpha2-adrenoceptors in the brain of suicide victims. increased receptor density associated with major depression Biol Psychiatry. 31:1992;471-490.
37. Meana J.J., Garcia-Sevilla J.A. Increased alpha2-adrenoceptor density in the frontal cortex of depressed suicide victims. J Neural Transm. 70:1987;377-381.
38. Molderings G.J., Bonisch H., Hammermann R., Gothert M., Bruss M. Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors. similarities to presynaptic imidazoline and edg receptors Neurochem Int. 40:2002;157-167.
39. Morris J.S., Ohman A., Dolan R.J. Conscious and unconscious emotional learning in the human amygdala. Nature. 393:1998;467-470.
40. 1-imidazoline binding sites. Annals New York Academy of Sciences. 881:1999;59-60.
41. Ordway G.A., Widdowson P.S., Streator-Smith K., Halaris A. Agonist binding to alpha-2 adrenoceptors is elevated in the locus coeruleus from victims of suicide. Journal of Neurochemistry. 63:1994;617-624.
42. Parsons W.B. Jr., Morledge J.H. Antihypertensive effect of a new imidazoline compound (clonidine) and chlorthalidone, individually and in combination. Am J Cardiol. 26:1970;258-261.
43. Piletz J.E., Ivanov T.R., Sharp J.D., Ernsberger P., Chang C.H., Pickard R.T.et al. Imidazoline receptor antisera-selected (IRAS) cDNA. cloning and characterization DNA Cell Biol. 19:2000;319-329.
44. 3H]-clonidine binding to non-adrenergic sitres and alpha2-adrenergic receptors in human brain. Neuropsychopharmacology. 23:2000;697-708.
45. Piletz J.E., Zhu H., Ordway G., Stockmeier C., Dilly G., Reis D., Halaris A. Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression. Biol Psychiatry. 48:2000;910-919.
46. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y.et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry. 45:1999;1085-1098.
47. Rauch S.L., van der Kolk B.A., Fisler R.E., Alpert N.M., Orr S.P., Savage C.R.et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry. 53:1996;380-387.
48. Sastre M., Garcia-Sevilla J.A. Opposite age-dependent changes of alpha-2a adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2 imidazoline sites) in the human brain; strong correlation of I2 with monoamine oxidase-B sites. J Neurochem. 61:1993;881-889.
49. Sims K.S., Williams R.S. The human amygdaloid complex. a cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining Neuroscience. 36:1990;449-472.
50. Tolentino-Silva F.P., Haxhiu M.A., Waldbaum S., Dreshaj I.A., Ernsberger P. Alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice. Brain Res. 862:2000;26-35.